What is Syndesmodysplasic dwarfism?
Syndesmodysplasic dwarfism does not yet have FDA-approved treatments tracked on UniteRare.
Also known as:
Key symptoms:
Short stature (dwarfism)Shortened limbsJoint abnormalities or stiffnessAbnormal bone developmentSpinal abnormalitiesUnusual facial featuresSmall chestDelayed motor milestonesLimited range of motion in joints
- Inheritance
- Autosomal recessive
- Passed on when both parents carry the same gene change; often skips generations
- Age of Onset
- Neonatal
- Begins at or shortly after birth (first 4 weeks)
Treatments
Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly
No FDA-approved treatments are currently listed for Syndesmodysplasic dwarfism.
View clinical trials →Clinical Trials
View all trials with filters →Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest
No actively recruiting trials found for Syndesmodysplasic dwarfism at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)
No specialists are currently listed for Syndesmodysplasic dwarfism.
Treatment Centers
8 centersSource: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months
Children's Hospital Colorado Rare Disease Program ↗
Children's Hospital Colorado
📍 Aurora, CO
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDBoston Children's Hospital Rare Disease Program ↗
Boston Children's Hospital
📍 Boston, MA
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
🏨 Children'sAnn & Robert H. Lurie Children's Hospital Genetics ↗
Lurie Children's Hospital
📍 Chicago, IL
👤 Boston Children's Hospital Rare Disease Program
🏥 NORDCincinnati Children's Hospital Medical Center ↗
Cincinnati Children's
📍 Cincinnati, OH
👤 Boston Children's Hospital Rare Disease Program
🏨 Children'sNationwide Children's Hospital Rare Disease Center ↗
Nationwide Children's Hospital
📍 Columbus, OH
👤 Boston Children's Hospital Rare Disease Program
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
Travel Grants
No travel grants are currently matched to Syndesmodysplasic dwarfism.
Community
No community posts yet. Be the first to share your experience with Syndesmodysplasic dwarfism.
Start the conversation →Latest news about Syndesmodysplasic dwarfism
Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC
No recent news articles for Syndesmodysplasic dwarfism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific skeletal abnormalities does my child have, and how might they change over time?,Should we pursue genetic testing to look for a specific cause?,What kind of physical therapy or orthopedic treatments would be most helpful?,Are there any breathing concerns we should watch for?,How often should we schedule follow-up appointments and imaging?,Are there other skeletal dysplasias that should be ruled out?,What resources or specialists can help us manage this condition long-term?
Common questions about Syndesmodysplasic dwarfism
What is Syndesmodysplasic dwarfism?
Syndesmodysplasic dwarfism is an extremely rare skeletal disorder that affects bone and joint development, leading to short stature (dwarfism). The name comes from 'syndesmo,' referring to connective tissue and ligaments, and 'dysplasic,' meaning abnormal development. This condition is characterized by problems with the way bones grow and how joints are formed, resulting in a person being significantly shorter than average. Affected individuals may have joint abnormalities, limb shortening, and other skeletal malformations that are typically noticed at birth or in early infancy. Because this
How is Syndesmodysplasic dwarfism inherited?
Syndesmodysplasic dwarfism follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Syndesmodysplasic dwarfism typically begin?
Typical onset of Syndesmodysplasic dwarfism is neonatal. Age of onset can vary across affected individuals.
Frequently asked questions about Syndesmodysplasic dwarfism
Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.
What is Syndesmodysplasic dwarfism?
Syndesmodysplasic dwarfism is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:2654, OMIM 272450). It is typically inherited as autosomal recessive. Age of onset is generally neonatal. For verified primary sources, see the UniteRare Syndesmodysplasic dwarfism page.
How is Syndesmodysplasic dwarfism inherited?
Syndesmodysplasic dwarfism follows autosomal recessive inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.
Are there FDA-approved treatments for Syndesmodysplasic dwarfism?
Approved treatments for Syndesmodysplasic dwarfism are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.
Are there clinical trials for Syndesmodysplasic dwarfism?
Active clinical trials for Syndesmodysplasic dwarfism are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.
How do I find a specialist for Syndesmodysplasic dwarfism?
Verified Syndesmodysplasic dwarfism specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.
See full Syndesmodysplasic dwarfism page for complete clinical details, sources, and verified-specialist listings.
Cite this page
Select a citation format above to view and copy.